BVMF/B1ME34 (BVMF/B1ME34)

Brazil Stock Exchange: BVMF/B1ME34 · BRL

R$72.4

+0.00 (0.0%)· Recorded snapshot

Market cap	222.5B
Revenue (ttm)	31.8B
Net income (ttm)	3.4B
EPS (ttm)	R$1.11
P/E (trailing)	65.2x
P/E (forward)	45.7x
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.8B
Net income (ttm): 3.4B
EPS (ttm): R$1.11
P/E (trailing): 65.2x
P/E (forward): 45.7x
Market cap: 222.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E45.7

P25 n/aP50 n/aP75 n/a

Trailing P/E65.2

P25 n/aP50 n/aP75 n/a

ROE14.7

P25 n/aP50 n/aP75 n/a

ROIC33.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/B1ME34 indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Switzerland
Country code	BR
Earnings date	2026-11-05
Employees	12,000
Employees change	1,000
Employees growth	9.09%
Enterprise value	BRL 206.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	No
ISIN number	BRB1MEBDR009
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	BRL 222.5B
Next earnings date	2026-11-05
Price	BRL 72.38
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-05
Symbol	bvmf/B1ME34
Website	https://beonemedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.53%
EV/Earnings	60.71x
EV/EBIT	41.83x
EV/EBITDA	35.06x
EV/FCF	29.93x
EV/Sales	6.29x
FCF / EV yield	3.34%
FCF yield	3.1%
Forward P/E	45.73x
Graham number	14.72145
Graham upside	-79.66%
P/(FCF - SBC) ratio	53.37x
P/(OCF - SBC) ratio	44.81x
P/B ratio	8.3x
P/E ratio	65.25x
P/FCF ratio	32.29x
P/OCF ratio	28.95x
P/S ratio	7.01x
Price / tangible book value	8.4x
Price/EBITDA ratio	40.09x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.06%
EBITDA margin	17.48%
Effective tax rate	24.46%
FCF margin	20.87%
Gross margin	88.89%
Operating margin	15.06%
Pretax margin	14.16%
Profit margin	10.7%
Profit per employee	BRL 283,091
Profitable quarters	6
Profitable years	1
Revenue per employee	BRL 2.6M
ROA	7.46%
ROA (5Y)	-8.44%
ROCE	13.08%
ROE	14.66%
ROE (5Y)	-20.17%
ROIC	33.62%
SBC / revenue	8.57%
Tax / revenue	3.47%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	166.67%
EPS growth (QoQ)	6.67%
EPS growth quarters	7
EPS growth years	3
FCF growth	443.29%
FCF growth (Q)	98.09%
FCF growth (QoQ)	171.16%
Gross profit growth	39.65%
Gross profit growth (Q)	33.01%
Gross profit growth 3Y	34.26%
Net income growth (Q)	151.28%
Net income growth (QoQ)	4.24%
Net income growth quarters	7
Net income growth years	3
OCF growth	159.81%
OCF growth (Q)	75.58%
OCF growth (QoQ)	129.87%
Operating income growth (Q)	269.85%
Revenue growth	34.35%
Revenue growth (Q)	29.63%
Revenue growth (QoQ)	12.66%
Revenue growth 10Y	96.54%
Revenue growth 3Y	50.14%
Revenue growth 5Y	45.28%
Revenue growth quarters	17
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -797.2M
Depreciation and amortization	BRL 800M
EBIT	BRL 4.8B
EBITDA	BRL 5.6B
EPS	BRL 1.11
Financing cash flow	BRL 5.8B
Free cash flow	BRL 6.9B
Free cash flow minus SBC	BRL 4.2B
Gross profit	BRL 28.2B
Income taxes	BRL 1.1B
Investing cash flow	BRL -945.4M
Net borrowing	BRL 583.8M
Net cash flow	BRL 12.9B
Net income	BRL 3.4B
Operating cash flow minus SBC	BRL 5B
Operating income	BRL 4.8B
Revenue	BRL 31.8B
Stock-based compensation	BRL 2.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.65
Book value per share	BRL 237.17
Debt / EBITDA	1.86
Debt / equity	0.4
Debt / FCF	1.54
Interest coverage	7.97
Long-term assets	BRL 8.7B
Long-term liabilities	BRL 9.3B
Net cash (debt)	BRL 15.8B
Net cash / market cap	7.1%
Net cash growth	76.18%
Net debt / EBITDA	-2.84
Net debt / equity	-0.59
Net debt / FCF	-2.29
Piotroski F-Score	7
Property, plant and equipment	BRL 9.6B
Shareholders' equity	BRL 26.8B
Tangible book value	BRL 26.5B
Tangible book value per share	BRL 234.38
Total assets	BRL 47.5B
Total cash	BRL 26.4B
Total debt	BRL 10.6B
Total liabilities	BRL 20.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.79
Current assets	BRL 38.9B
Current liabilities	BRL 11.4B
Current ratio	3.4
Inventory turnover	1.1
Net working capital	BRL 1.6B
Quick ratio	2.91
Working capital	BRL 26.4B
Working capital turnover	8.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.01%
Shareholder yield	-8.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 53.10
1D price change	0%
1M price change	-2.19%
1M total return	-2.19%
1W price change	-0.48%
1W total return	-0.48%
1Y price change	1.67%
1Y return CAGR	1.67%
1Y total return	1.67%
20-day SMA	BRL 63.84
200-day SMA	BRL 48.10
3M price change	20.88%
3M total return	20.88%
3Y price change	102.41%
3Y return CAGR	26.49%
3Y total return	102.41%
50-day SMA	BRL 62.59
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 74.00
52-week high date	2026-08-31
52-week low	BRL 54.00
52-week low date	2026-06-15
6M price change	16.87%
6M total return	16.87%
All-time high	BRL 74.00
All-time high date	2026-08-31
All-time low	BRL 27.12
All-time low date	2024-04-19
Average true range (ATR)	BRL 2.56
Average volume	197.4
Change from 52-week high	-2.19%
Change from 52-week low	34.04%
Change from all-time high	-2.19%
Change from all-time low	166.89%
Change from open	0%
Day's gap	0%
High price	BRL 72.38
Low price	BRL 72.38
Monthly RSI	61.27
Open price	BRL 72.38
Previous close	BRL 72.38
Price vs 150-day SMA	36.31%
Price vs 20-day SMA	13.39%
Price vs 200-day SMA	50.48%
Price vs 50-day SMA	15.64%
Relative volume	0.04
RSI	61.94
Sharpe ratio	0.74
Sortino ratio	1.26
Volume	0
Weekly RSI	60.58
YTD price change	3.4%
YTD total return	3.4%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81M
Shares change (QoQ)	0.02%
Shares change (YoY)	8.01%
Short ratio	4.7 days

Deeper analysis on BVMF/B1ME34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/B1ME34 report

Is a complete BVMF/B1ME34 research report available?

No complete published report is available for bvmf/B1ME34 (BVMF/B1ME34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/B1ME34 (BVMF/B1ME34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/B1ME34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/B1ME34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/B1ME34

Frequently asked questions